Anne-Marie Koop

9 319 48. Nagendran J, Gurtu V, Fu DZ, Dyck JRB, Haromy A, Ross DB, Rebeyka IM, Michelakis ED. A dynamic and chamber-specific mitochondrial remodeling in right ventricular hypertrophy can be therapeutically targeted. J Thorac Cardiovasc Surg E.D. Michelakis, Pulmonary Hypertension Program, Department of Medicine, University of Alberta, Edmonton, Alta., Canada; 2008;136:168-178.e3. 49. Arron JR, Winslow MM, Polleri A, Chang CP, Wu H, Gao X, Neilson JR, Chen L, Heit JJ, Kim SK, Yamasaki N, Miyakawa T, Francke U, Graef IA, Crabtree GR. NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21. Nature 2006;441:595–600. 50. Gwack Y, Sharma S, Nardone J, Tanasa B, Iuga A, Srikanth S, Okamura H, Bolton D, Feske S, Hogan PG, Rao A. A genome-wide Drosophila RNAi screen identifies DYRK-family kinases as regulators of NFAT. Nature 2006;441:646–650. 51. Costa Martins PA da, Salic K, Gladka MM, Armand A-S, Leptidis S, Azzouzi H el, Hansen A, Coenen-de Roo CJ, Bierhuizen MF, Nagel R van der, Kuik J van, Weger R de, Bruin A de, Condorelli G, Arbones ML, Eschenhagen T, Windt LJ De. MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling. Nat Cell Biol Nature Publishing Group; 2010;12:1220–1227. 52. Reddy S, Zhao M, Hu D-Q, Fajardo G, Hu S, Ghosh Z, Rajagopalan V, Wu JC, Bernstein D. Dynamic microRNA expression during the transition from right ventricular hypertrophy to failure. Physiol Genomics 2012;44:562–575. 53. Srivastava D, Thomas T, Lin Q, Kirby ML, Brown D, Olson EN. Regulation of cardiac mesodermal and neural crest development by the bHLH transcription factor, dHAND. Nat Genet 1997;16:154–160. 54. Shen L, Li XF, Shen AD, Wang Q, Liu CX, Guo YJ, Song ZJ, Li ZZ. Transcription factor HAND2 mutations in sporadic chinese patients with congenital heart disease. Chin Med J (Engl) 2010;123:1623–1627. 55. Sun Y-M, Wang J, Qiu X-B, Yuan F, Li R-G, Xu Y-J, Qu X-K, Shi H-Y, Hou X-M, Huang R-T, Xue S, Yang Y-Q. A HAND2 loss-of-function mutation causes familial ventricular septal defect and pulmonary stenosis. G3 Genes, Genomes, Genet J. Wang, Department of Cardiology, Jing’an District Central Hospital, Shanghai, China; 2016;6:987–992. 56. Dirkx E, Gladka MM, Philippen LE, Armand A, Kinet V, Leptidis S, Azzouzi H, Salic K, Bourajjaj M, Silva GJJ, Olieslagers S, Nagel R Van Der, Weger R De, Bitsch N, Kisters N, Seyen S, Morikawa Y, Chanoine C, Heymans S, Volders PGA, ThumT, Dimmeler S, Cserjesi P, Eschenhagen T, Paula A, Martins C, Windt LJ De, Azzouzi H El, Salic K, Bourajjaj M, et al. Nfat and miR-25 cooperate to reactivate the transcription factor Hand2 in heart failure. Nat Cell Biol Nature Publishing Group; 2013;15:1282–1293. 57. Kasner M, Westermann D, Steendijk P, Dros̈e S, Poller W, Schultheiss HP, Tschöpe C. Left ventricular dysfunction induced by nonsevere idiopathic pulmonary arterial hypertension: A pressure-volume relationship study. Am J Respir Crit Care M ed 2012;186:181–189. 58. Damiano RJ, Follette P La, Cox JL, Lowe JE, Santamore WP. Significant left ventricular contribution to right ventricular systolic function. Am J Physiol - Hear Circ Physiol 1991;261. 59. Goldstein JA, Harada A, Yagi Y, Barzilai B, Cox JL. Hemodynamic importance of systolic ventricular interaction, augmented right atrial contractility and atrioventricular synchorny in acute right ventricular dysfunction. J Am Coll Cardiol 1990; 16 :181–189.